These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 9016909

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
    Noble F, Smadja C, Roques BP.
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
    Valverde O, Maldonado R, Fournie-Zaluski MC, Roques BP.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CCKA, but not CCKB, agonists suppress the hyperlocomotion induced by endogenous enkephalins, protected from enzymatic degradation by systemic RB 101.
    Dauge V, Corringer PJ, Roques BP.
    Pharmacol Biochem Behav; 1995 Feb; 50(2):133-9. PubMed ID: 7740050
    [Abstract] [Full Text] [Related]

  • 8. Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot plate test in mice.
    Derrien M, Noble F, Maldonado R, Roques BP.
    Neurosci Lett; 1993 Oct 01; 160(2):193-6. PubMed ID: 8247353
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association of the peptidase inhibitor RB 101 and a CCK-B antagonist strongly enhances antinociceptive responses.
    Maldonado R, Derrien M, Noble F, Roques BP.
    Neuroreport; 1993 Jul 01; 4(7):947-50. PubMed ID: 8369487
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C, Lazzeri G, Colucci R, Carignani D, Tognetti M, Baschiera F, Del Tacca M.
    Eur J Pharmacol; 1999 May 28; 373(1):71-84. PubMed ID: 10408253
    [Abstract] [Full Text] [Related]

  • 14. Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5-17) different in stimulating acid secretion in isolated rabbit gastric glands?
    Oiry C, Galleyrand JC, Lima-Leite AC, Fulcrand P, Martinez J.
    Eur J Pharmacol; 1995 Dec 29; 294(2-3):511-9. PubMed ID: 8750713
    [Abstract] [Full Text] [Related]

  • 15. The antagonistic effect of cholecystokinin octapeptide (CCK-8) on opioid effects in cardiovascular activities was mediated by CCK-B receptor.
    Mei L, Han JS.
    Sci China B; 1993 Jul 29; 36(7):817-23. PubMed ID: 8216742
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CCK-B receptors in the limbic system modulate the antidepressant-like effects induced by endogenous enkephalins.
    Smadja C, Ruiz F, Coric P, Fournié-Zaluski MC, Roques BP, Maldonado R.
    Psychopharmacology (Berl); 1997 Aug 29; 132(3):227-36. PubMed ID: 9292622
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.